Home » Topics » Cardiovascular, BioWorld Science

Cardiovascular, BioWorld Science
RSS

Trial results of rhVEGF165 in CAD disappointing

Feb. 23, 1999

AVI BioPharma presents data from preclinical study of Resten-NG in restenosis

Feb. 22, 1999

Renal protective effects of azelnidipine involve inhibition of AGE production

Feb. 22, 1999

Antihypertensive effects of bradykinin agonist FR-190997 evaluated in animals

Feb. 22, 1999

Novel antihypertensive drug candidate available for licensing from VUFB

Feb. 19, 1999

Amlodipine not associated with adverse arrhythmic events in CAD patients

Feb. 18, 1999

Patent covers new ADIR compounds with high affinity for imidazoline receptors

Feb. 18, 1999

New vasopeptidase inhibitor advances in clinical trials at Bristol-Myers Squibb

Feb. 17, 1999

Roche recovers marketing rights for beta-blocker in most markets

Feb. 15, 1999

Angiotensin II blocker/diuretic combination product added to Spanish pharmacopeia

Feb. 15, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Molecular signatures show subtypes in neurodegenerative diseases
BioWorld Science
Parkinson’s disease is a progressive neurodegenerative disorder best known for its motor symptoms. However, a proportion of patients also develop dementia as the...
More than two to tango: multispecifics at ESMO TAT
BioWorld Science
Multispecifics took center stage at this year’s ESMO TAT, emerging as one of the hottest trends in oncology research. Unlike traditional small-molecule drugs or...